Brachial Plexus Injury Market Report 2024

The brachial plexus injury market size has grown rapidly in recent years. It will grow from $5.1 billion in 2023 to $5.73 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. The historic period's growth can be attributed to several factors, including a rise in trauma from road accidents and sports injuries, increased awareness and early diagnosis of brachial plexus injuries, advancements in healthcare infrastructure and accessibility to treatment, a growing elderly population susceptible to neurological conditions, expanded healthcare insurance coverage for complex surgeries, and regulatory approvals for new treatment options.

The brachial plexus injury market size is expected to see rapid growth in the next few years. It will grow to $9.22 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. The anticipated growth during the forecast period can be attributed to several factors, an aging population driving higher demand for nerve repair solutions, the use of advanced imaging techniques for precise diagnosis, the adoption of minimally invasive surgical procedures, increased investment in R&D for biologics and tissue engineering, rising healthcare spending in developing economies, and partnerships between medical device companies and research institutions. Key trends for the forecast period include the use of robotic-assisted surgery for accurate nerve reconstruction, expansion of telemedicine and virtual consultations for post-operative care, development of bioresorbable materials for nerve conduits, application of artificial intelligence for personalized treatment plans, growth of outpatient surgical centers for faster recovery, a focus on patient-reported outcomes and quality of life improvements, and a shift towards personalized medicine and customized rehabilitation programs.

An anticipated increase in road accidents is likely to drive the growth of the brachial plexus injury market. Rising vehicle usage and insufficient enforcement of traffic laws exacerbate risks related to speeding and driver negligence, leading to a higher incidence of road accidents. Brachial plexus injury treatment in road accidents often includes surgical procedures, such as nerve grafting or nerve transfer, combined with rehabilitative therapies to restore limb function and mobility. For example, in January 2024, according to a report by The Road Safety Authority, an Ireland-based government agency, revealed that road deaths in 2023 had increased by 19% compared to 2022. This rise in road accidents is consequently boosting the brachial plexus injury market.

Leading companies in the brachial plexus injury market are advancing medical therapies, such as long-acting local analgesics, to improve pain management. These analgesics are crucial for managing pain in brachial plexus injuries, providing prolonged relief through nerve blocks or local infiltration methods, thus enhancing patient comfort, aiding rehabilitation, and reducing the systemic side effects of traditional pain medications. For instance, in March 2021, Pacira BioSciences Inc., a US-based specialty pharmaceutical company, received FDA approval to expand the indications for its non-opioid pain medication, EXPAREL (bupivacaine liposome injectable suspension). This approval included two additional nerve block indications, the Adductor canal block for regional analgesia in lower extremity treatments, and the Sciatic nerve block in the popliteal fossa for lower extremity surgeries. The supplemental new drug application (sNDA) was based on successful Phase 3 studies showing that EXPAREL significantly reduced postsurgical pain and opioid use over 96 hours compared to bupivacaine HCl after procedures such as bunionectomy and total knee arthroplasty.

In January 2024, Catholic Medical Center (CMC), a US-based nonprofit acute-care hospital and regional health system, merged with HCA Healthcare Inc. for an undisclosed amount. This merger is designed to continue and enhance CMC’s health and healing mission, support its operations, and invest in its people and facilities, thereby strengthening regional healthcare delivery in the long term. HCA Healthcare Inc., a US-based healthcare service company, provides treatment for brachial plexus injuries.

Major companies operating in the brachial plexus injury market are Cardinal Health Inc., Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Terumo Corporation, Smith And Nephew plc, Arthrex Inc., Teleflex Incorporated, Karl Storz SE And Co. KG, Cook Medical LLC, Integra LifeSciences Holdings Corporation, CONMED Corporation, DJO Global Inc., LivaNova PLC, MicroPort Scientific Corporation, Wright Medical Group N.V., AngioDynamics Inc., Pentax Medical.

North America was the largest region in the brachial plexus injury market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brachial plexus injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the brachial plexus injury market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A brachial plexus injury refers to damage or trauma to the network of nerves that control movement and sensation in the shoulder, arm, and hand. This type of injury often results from accidents, complications during childbirth, or sports injuries, leading to a range of impairments from mild weakness to complete paralysis. Treatment varies based on the severity of the injury and typically involves a combination of approaches.

The main types of brachial plexus injuries include avulsion, rupture, neurapraxia, axonotmesis, neurotmesis, and neuroma. Avulsion occurs when a nerve is entirely torn away from its attachment to the spinal cord and usually requires complex surgical procedures to restore function. Diagnosis is based on clinical examination, electrodiagnostic tests, and imaging studies, while treatment options such as therapy and surgery address issues related to trauma, inflammation, contact sports, tumors, radiation treatment, and other causes.

The brachial plexus injury market research report is one of a series of new reports that provides brachial plexus injury market statistics, including brachial plexus injury industry global market size, regional shares, competitors with an brachial plexus injury market share, detailed brachial plexus injury market segments, market trends and opportunities, and any further data you may need to thrive in the brachial plexus injury industry. This brachial plexus injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The brachial plexus injury market consists of revenues earned by entities providing services such as surgical interventions, rehabilitation therapies, diagnostic imaging, and long-term care management for individuals affected by brachial plexus injuries. The market value includes the value of related goods sold by the service provider or included within the service offering. The brachial plexus injury market also includes sales of surgical implants, orthotic devices, pain management medications, and diagnostic equipment used for assessing nerve function and injury severity. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.